Written by international experts in the field, this new guide examines cutting-edge clinical studies that investigate innovative therapies and related topics for leukemia and lymphoma. Innovative Leukemia and Lymphoma Therapy is the only comprehensive and up-to-date overview of the exciting new treatment modalities in leukemia and lymphoma in practice today. It covers:.: Leukemia and lymphoma including: tyrosine kinase inhibitors, histon deacetylase inhibitors, and farnesyl transferase inhibitors.; Radioimmunotherapy, gene-directed therapy, and immunotherapy by vaccination.; Monoclonal antibodies.; Anti-angiogenesis approaches.; The concerns of conventional but novel anticancer agents.; Modulation of classical multidrug resistancemodulators of single agent drug resistance.